Carla Boccaccio

Candiolo Cancer Institute

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (14)

Francesca De Bacco

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

LAURA CASORZO

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

Livio Trusolino

Full Professor, University of Torino School of Medicine

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

Eliano Cascardi

University of Turin

ITALY

View details

Ilaria Rancati

Head of Cell Biology Unit

ITALY

View details

Dogus Altintas

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Pietro Luigi Poliani

University of Brescia

ITALY

View details

Alessandro Arcovito

Associate Professor

Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia

ITALY

View details

Noemi Gioelli

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

GIGLIOLA REATO

University of Turin

ITALY

View details

Serena Brundu

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

Tiziana Crepaldi

PROFESSOR of BIOCHEMISTRY

University of Turin

ITALY

View details

Giulia Franzolin

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

Guido Serini

Full Professor

University of Turin

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carla Boccaccio

Research Interests

Explore related searches

Contact this professor

Articles (13)

Androgen receptor inhibition sensitizes glioblastoma stem cells to temozolomide by the miR-1/miR-26a-1/miR-487b signature mediated WT1 and FOXA1 silencing

The integrated stress response drives MET oncogene overexpression in cancers

An mTOR feedback loop mediates the 'flare' ('rebound') response to MET tyrosine kinase inhibition.

Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary

MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis.

Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation.

Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas.

MET∆14 promotes a ligand-dependent, AKT-driven invasive growth

The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor.

ERBB3 as a therapeutic target in glioblastoma: overexpression can make the difference

ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma

Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition.

The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3.

Collaborators (14)

Francesca De Bacco

LAURA CASORZO

Livio Trusolino

Eliano Cascardi

Ilaria Rancati

Dogus Altintas

Pietro Luigi Poliani

Alessandro Arcovito

Noemi Gioelli

GIGLIOLA REATO

Serena Brundu

Tiziana Crepaldi

Giulia Franzolin

Guido Serini

Make your next move.